 | • レポートコード：D0804-00206 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アゴメラチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。アゴメラチンの種類別市場規模（セロトニン2Cアゴニスト、メラトニン受容体2アゴニスト、メラトニン受容体1アゴニスト、セロトニン受容体アゴニスト、セロトニン2C受容体アンタゴニスト）、用途別市場規模（うつ病、強迫性障害、睡眠障害、全身性不安障害、多発性硬化症、全身性外傷性疼痛、自閉症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Servier、Nectid Inc、Rovi Pharma、Novartis、Jiangsu Haosen Pharmaceutical Group ・地域別グローバル市場分析 2015年-2020年 ・アゴメラチンの北米市場（アメリカ、カナダ、メキシコ） ・アゴメラチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アゴメラチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アゴメラチンの南米市場（ブラジル、アルゼンチン） ・アゴメラチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：セロトニン2Cアゴニスト、メラトニン受容体2アゴニスト、メラトニン受容体1アゴニスト、セロトニン受容体アゴニスト、セロトニン2C受容体アンタゴニスト ・用途別分析：うつ病、強迫性障害、睡眠障害、全身性不安障害、多発性硬化症、全身性外傷性疼痛、自閉症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Agomelatine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Agomelatine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
This report also the impact of Covid-19 outbreak on the Agomelatine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Agomelatine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Agomelatine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Agomelatine market has been segmented into
Serotonin 2C Agonist
Melatonin Receptor 2 Agonist
Melatonin Receptor 1 Agonist
Serotonin Receptor Agonist
Serotonin 2C Receptor Antagonist
By Application, Agomelatine has been segmented into:
Depression
Obsessive Compulsive Disorder
Sleep Disorders
Generalized Anxiety Disorder
Multiple Sclerosis
Systemic Traumatic Pain
Autism
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Agomelatine market presented in the report. This section sheds light on the sales growth of different regional and country-level Agomelatine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Agomelatine market.
The report offers in-depth assessment of the growth and other aspects of the Agomelatine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Agomelatine Market Share Analysis
Agomelatine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Agomelatine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Agomelatine sales, revenue and market share for each player covered in this report.
The major players covered in Agomelatine are:
Servier
Nectid Inc
Rovi Pharma
Novartis
Jiangsu Haosen Pharmaceutical Group
Among other players domestic and global, Agomelatine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Agomelatine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Agomelatine, with price, sales, revenue and global market share of Agomelatine in 2018 and 2019.
Chapter 3, the Agomelatine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Agomelatine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Agomelatine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Agomelatine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Agomelatine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Agomelatine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Serotonin 2C Agonist
1.2.3 Melatonin Receptor 2 Agonist
1.2.4 Melatonin Receptor 1 Agonist
1.2.5 Serotonin Receptor Agonist
1.2.6 Serotonin 2C Receptor Antagonist
1.3 Market Analysis by Application
1.3.1 Overview: Global Agomelatine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Depression
1.3.3 Obsessive Compulsive Disorder
1.3.4 Sleep Disorders
1.3.5 Generalized Anxiety Disorder
1.3.6 Multiple Sclerosis
1.3.7 Systemic Traumatic Pain
1.3.8 Autism
1.3.9 Other
1.4 Overview of Global Agomelatine Market
1.4.1 Global Agomelatine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Agomelatine Industry Impact
1.6.1 COVID-19 Potential Implications for the Agomelatine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Agomelatine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Servier
2.1.1 Servier Details
2.1.2 Servier Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Servier SWOT Analysis
2.1.4 Servier Product and Services
2.1.5 Servier Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nectid Inc
2.2.1 Nectid Inc Details
2.2.2 Nectid Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nectid Inc SWOT Analysis
2.2.4 Nectid Inc Product and Services
2.2.5 Nectid Inc Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Rovi Pharma
2.3.1 Rovi Pharma Details
2.3.2 Rovi Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Rovi Pharma SWOT Analysis
2.3.4 Rovi Pharma Product and Services
2.3.5 Rovi Pharma Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Jiangsu Haosen Pharmaceutical Group
2.5.1 Jiangsu Haosen Pharmaceutical Group Details
2.5.2 Jiangsu Haosen Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Jiangsu Haosen Pharmaceutical Group SWOT Analysis
2.5.4 Jiangsu Haosen Pharmaceutical Group Product and Services
2.5.5 Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Agomelatine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Agomelatine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Agomelatine Manufacturer Market Share in 2019
3.3.2 Top 6 Agomelatine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Agomelatine Sales, Revenue and Market Share by Regions
4.1.1 Global Agomelatine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Agomelatine Revenue and Market Share by Regions (2015-2020)
4.2 North America Agomelatine Sales and Growth Rate (2015-2020)
4.3 Europe Agomelatine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Agomelatine Sales and Growth Rate (2015-2020)
4.5 South America Agomelatine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Agomelatine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Agomelatine Sales, Revenue and Market Share by Country
5.1.1 North America Agomelatine Sales and Market Share by Country (2015-2020)
5.1.2 North America Agomelatine Revenue and Market Share by Country (2015-2020)
5.2 United States Agomelatine Sales and Growth Rate (2015-2020)
5.3 Canada Agomelatine Sales and Growth Rate (2015-2020)
5.4 Mexico Agomelatine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Agomelatine Sales, Revenue and Market Share by Country
6.1.1 Europe Agomelatine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Agomelatine Revenue and Market Share by Country (2015-2020)
6.2 Germany Agomelatine Sales and Growth Rate (2015-2020)
6.3 UK Agomelatine Sales and Growth Rate (2015-2020)
6.4 France Agomelatine Sales and Growth Rate (2015-2020)
6.5 Russia Agomelatine Sales and Growth Rate (2015-2020)
6.6 Italy Agomelatine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Agomelatine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Agomelatine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Agomelatine Revenue and Market Share by Regions (2015-2020)
7.2 China Agomelatine Sales and Growth Rate (2015-2020)
7.3 Japan Agomelatine Sales and Growth Rate (2015-2020)
7.4 Korea Agomelatine Sales and Growth Rate (2015-2020)
7.5 India Agomelatine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Agomelatine Sales and Growth Rate (2015-2020)
7.7 Australia Agomelatine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Agomelatine Sales, Revenue and Market Share by Country
8.1.1 South America Agomelatine Sales and Market Share by Country (2015-2020)
8.1.2 South America Agomelatine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Agomelatine Sales and Growth Rate (2015-2020)
8.3 Argentina Agomelatine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Agomelatine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Agomelatine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Agomelatine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Agomelatine Sales and Growth Rate (2015-2020)
9.3 Turkey Agomelatine Sales and Growth Rate (2015-2020)
9.4 Egypt Agomelatine Sales and Growth Rate (2015-2020)
9.5 South Africa Agomelatine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Agomelatine Sales and Market Share by Type (2015-2020)
10.2 Global Agomelatine Revenue and Market Share by Type (2015-2020)
10.3 Global Agomelatine Price by Type (2015-2020)
11 Global Agomelatine Market Segment by Application
11.1 Global Agomelatine Sales Market Share by Application (2015-2020)
11.2 Global Agomelatine Revenue Market Share by Application (2015-2020)
11.3 Global Agomelatine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Agomelatine Sales, Revenue and Growth Rate (2021-2025)
12.2 Agomelatine Market Forecast by Regions (2021-2025)
12.2.1 North America Agomelatine Market Forecast (2021-2025)
12.2.2 Europe Agomelatine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Agomelatine Market Forecast (2021-2025)
12.2.4 South America Agomelatine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Agomelatine Market Forecast (2021-2025)
12.3 Agomelatine Market Forecast by Type (2021-2025)
12.3.1 Global Agomelatine Sales Forecast by Type (2021-2025)
12.3.2 Global Agomelatine Market Share Forecast by Type (2021-2025)
12.4 Agomelatine Market Forecast by Application (2021-2025)
12.4.1 Global Agomelatine Sales Forecast by Application (2021-2025)
12.4.2 Global Agomelatine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Agomelatine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Agomelatine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Agomelatine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Agomelatine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Servier Basic Information, Manufacturing Base and Competitors
Table 9. Servier Agomelatine Major Business
Table 10. Servier Agomelatine Total Revenue (USD Million) (2018-2019)
Table 11. Servier SWOT Analysis
Table 12. Servier Agomelatine Product and Services
Table 13. Servier Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Nectid Inc Basic Information, Manufacturing Base and Competitors
Table 15. Nectid Inc Agomelatine Major Business
Table 16. Nectid Inc Agomelatine Total Revenue (USD Million) (2018-2019)
Table 17. Nectid Inc SWOT Analysis
Table 18. Nectid Inc Agomelatine Product and Services
Table 19. Nectid Inc Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Rovi Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Rovi Pharma Agomelatine Major Business
Table 22. Rovi Pharma Agomelatine Total Revenue (USD Million) (2018-2019)
Table 23. Rovi Pharma SWOT Analysis
Table 24. Rovi Pharma Agomelatine Product and Services
Table 25. Rovi Pharma Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Novartis Basic Information, Manufacturing Base and Competitors
Table 27. Novartis Agomelatine Major Business
Table 28. Novartis Agomelatine Total Revenue (USD Million) (2018-2019)
Table 29. Novartis SWOT Analysis
Table 30. Novartis Agomelatine Product and Services
Table 31. Novartis Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Jiangsu Haosen Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 33. Jiangsu Haosen Pharmaceutical Group Agomelatine Major Business
Table 34. Jiangsu Haosen Pharmaceutical Group Agomelatine Total Revenue (USD Million) (2018-2019)
Table 35. Jiangsu Haosen Pharmaceutical Group SWOT Analysis
Table 36. Jiangsu Haosen Pharmaceutical Group Agomelatine Product and Services
Table 37. Jiangsu Haosen Pharmaceutical Group Agomelatine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Global Agomelatine Sales by Manufacturer (2018-2019) (M Pcs)
Table 39. Global Agomelatine Revenue by Manufacturer (2018-2019) (USD Million)
Table 40. Global Agomelatine Sales by Regions (2015-2020) (M Pcs)
Table 41. Global Agomelatine Sales Market Share by Regions (2015-2020)
Table 42. Global Agomelatine Revenue by Regions (2015-2020) (USD Million)
Table 43. North America Agomelatine Sales by Countries (2015-2020) (M Pcs)
Table 44. North America Agomelatine Sales Market Share by Countries (2015-2020)
Table 45. North America Agomelatine Revenue by Countries (2015-2020) (USD Million)
Table 46. North America Agomelatine Revenue Market Share by Countries (2015-2020)
Table 47. Europe Agomelatine Sales by Countries (2015-2020) (M Pcs)
Table 48. Europe Agomelatine Sales Market Share by Countries (2015-2020)
Table 49. Europe Agomelatine Revenue by Countries (2015-2020) (USD Million)
Table 50. Asia-Pacific Agomelatine Sales by Regions (2015-2020) (M Pcs)
Table 51. Asia-Pacific Agomelatine Sales Market Share by Regions (2015-2020)
Table 52. Asia-Pacific Agomelatine Revenue by Regions (2015-2020) (USD Million)
Table 53. South America Agomelatine Sales by Countries (2015-2020) (M Pcs)
Table 54. South America Agomelatine Sales Market Share by Countries (2015-2020)
Table 55. South America Agomelatine Revenue by Countries (2015-2020) (USD Million)
Table 56. South America Agomelatine Revenue Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Agomelatine Sales by Countries (2015-2020) (M Pcs)
Table 58. Middle East & Africa Agomelatine Sales Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Agomelatine Revenue by Countries (2015-2020) (USD Million)
Table 60. Middle East & Africa Agomelatine Revenue Market Share by Countries (2015-2020)
Table 61. Global Agomelatine Sales by Type (2015-2020) (M Pcs)
Table 62. Global Agomelatine Sales Share by Type (2015-2020)
Table 63. Global Agomelatine Revenue by Type (2015-2020) (USD Million)
Table 64. Global Agomelatine Revenue Share by Type (2015-2020)
Table 65. Global Agomelatine Sales by Application (2015-2020) (M Pcs)
Table 66. Global Agomelatine Sales Share by Application (2015-2020)
Table 67. Global Agomelatine Sales Forecast by Regions (2021-2025) (M Pcs)
Table 68. Global Agomelatine Market Share Forecast by Regions (2021-2025)
Table 69. Global Agomelatine Sales Forecast by Type (2021-2025) (M Pcs)
Table 70. Global Agomelatine Market Share Forecast by Type (2021-2025)
Table 71. Global Agomelatine Sales Forecast by Application (2021-2025)
Table 72. Global Agomelatine Market Share Forecast by Application (2021-2025)
Table 73. Direct Channel Pros & Cons
Table 74. Indirect Channel Pros & Cons
Table 75. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Agomelatine Picture
Figure 2. Global Sales Market Share of Agomelatine by Type in 2019
Figure 3. Serotonin 2C Agonist Picture
Figure 4. Melatonin Receptor 2 Agonist Picture
Figure 5. Melatonin Receptor 1 Agonist Picture
Figure 6. Serotonin Receptor Agonist Picture
Figure 7. Serotonin 2C Receptor Antagonist Picture
Figure 8. Agomelatine Sales Market Share by Application in 2018
Figure 9. Depression Picture
Figure 10. Obsessive Compulsive Disorder Picture
Figure 11. Sleep Disorders Picture
Figure 12. Generalized Anxiety Disorder Picture
Figure 13. Multiple Sclerosis Picture
Figure 14. Systemic Traumatic Pain Picture
Figure 15. Autism Picture
Figure 16. Other Picture
Figure 17. Global Agomelatine Market Status and Outlook (2015-2025) (USD Million)
Figure 18. United States Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Canada Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Mexico Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Germany Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. France Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. UK Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Russia Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Italy Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. China Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Japan Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Korea Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. India Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Southeast Asia Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Australia Agomelatine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 32. Brazil Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Egypt Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Saudi Arabia Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 35. South Africa Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Turkey Agomelatine Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Global Agomelatine Sales Market Share by Manufacturer in 2019
Figure 38. Global Agomelatine Revenue Market Share by Manufacturer in 2019
Figure 39. Top 3 Agomelatine Manufacturer (Revenue) Market Share in 2019
Figure 40. Top 6 Agomelatine Manufacturer (Revenue) Market Share in 2019
Figure 41. Key Manufacturer Market Share Trend
Figure 42. Global Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 43. Global Agomelatine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. Global Agomelatine Revenue Market Share by Regions (2015-2020)
Figure 45. Global Agomelatine Revenue Market Share by Regions in 2018
Figure 46. North America Agomelatine Sales and Growth Rate (2015-2020)
Figure 47. Europe Agomelatine Sales and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Agomelatine Sales and Growth Rate (2015-2020)
Figure 49. South America Agomelatine Sales and Growth Rate (2015-2020)
Figure 50. Middle East & Africa Agomelatine Sales and Growth Rate (2015-2020)
Figure 51. North America Agomelatine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. North America Agomelatine Sales Market Share by Countries (2015-2020)
Figure 53. North America Agomelatine Sales Market Share by Countries in 2018
Figure 54. North America Agomelatine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 55. North America Agomelatine Revenue Market Share by Countries in 2018
Figure 56. United States Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 57. Canada Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 58. Mexico Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 59. Europe Agomelatine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Europe Agomelatine Revenue Market Share by Countries (2015-2020)
Figure 61. Europe Agomelatine Revenue Market Share by Countries in 2019
Figure 62. Germany Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 63. UK Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 64. France Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 65. Russia Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 66. Italy Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 67. Asia-Pacific Agomelatine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. Asia-Pacific Agomelatine Sales Market Share by Regions 2019
Figure 69. Asia-Pacific Agomelatine Revenue Market Share by Regions 2019
Figure 70. China Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 71. Japan Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 72. Korea Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 73. India Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 74. Southeast Asia Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 75. South America Agomelatine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. South America Agomelatine Sales Market Share by Countries in 2019
Figure 77. South America Agomelatine Revenue Market Share by Countries in 2019
Figure 78. Brazil Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 79. Argentina Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 80. Middle East and Africa Agomelatine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 81. Middle East and Africa Agomelatine Sales Market Share by Countries in 2019
Figure 82. Middle East and Africa Agomelatine Revenue Market Share by Countries (2015-2020)
Figure 83. Middle East and Africa Agomelatine Revenue Market Share by Countries in 2019
Figure 84. Saudi Arabia Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 85. Egypt Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 86. Turkey Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 87. South Africa Agomelatine Sales and Growth Rate (2015-2020) (M Pcs)
Figure 88. Global Agomelatine Sales and Growth Rate (2021-2025) (M Pcs)
Figure 89. Global Agomelatine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 90. North America Sales Agomelatine Market Forecast (2021-2025) (M Pcs)
Figure 91. Europe Sales Agomelatine Market Forecast (2021-2025) (M Pcs)
Figure 92. Asia-Pacific Sales Agomelatine Market Forecast (2021-2025) (M Pcs)
Figure 93. South America Sales Agomelatine Market Forecast (2021-2025) (M Pcs)
Figure 94. Middle East & Africa Sales Agomelatine Market Forecast (2021-2025) (M Pcs)
Figure 95. Sales Channel: Direct Channel vs Indirect Channel
スフィンゴシン1-リン酸受容体1の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Sphingosine 1-Phosphate Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…
- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…
- アンジオテンシン受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Angiotensin Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Angiotensin …
- スフィンゴシン-1-受容体調節薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Sphingosine-1-Receptor Modulators Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…